AR066664A1 - Un medicamento para tratar enfermedad de alzheimer - Google Patents

Un medicamento para tratar enfermedad de alzheimer

Info

Publication number
AR066664A1
AR066664A1 ARP080102154A ARP080102154A AR066664A1 AR 066664 A1 AR066664 A1 AR 066664A1 AR P080102154 A ARP080102154 A AR P080102154A AR P080102154 A ARP080102154 A AR P080102154A AR 066664 A1 AR066664 A1 AR 066664A1
Authority
AR
Argentina
Prior art keywords
disease
salts
medicinal product
treat alzheimer
medicament
Prior art date
Application number
ARP080102154A
Other languages
English (en)
Spanish (es)
Inventor
Heii Arai
Original Assignee
Otsuka Pharma Co Ltd
Univ Juntendo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ Juntendo filed Critical Otsuka Pharma Co Ltd
Publication of AR066664A1 publication Critical patent/AR066664A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP080102154A 2007-05-22 2008-05-21 Un medicamento para tratar enfermedad de alzheimer AR066664A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22

Publications (1)

Publication Number Publication Date
AR066664A1 true AR066664A1 (es) 2009-09-02

Family

ID=39636992

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102154A AR066664A1 (es) 2007-05-22 2008-05-21 Un medicamento para tratar enfermedad de alzheimer

Country Status (27)

Country Link
US (1) US20100298375A1 (OSRAM)
EP (2) EP2157973B1 (OSRAM)
JP (1) JP5153870B2 (OSRAM)
KR (1) KR101441725B1 (OSRAM)
CN (1) CN101754758B (OSRAM)
AR (1) AR066664A1 (OSRAM)
AU (1) AU2008253977B2 (OSRAM)
BR (1) BRPI0811919A2 (OSRAM)
CA (1) CA2687289C (OSRAM)
CO (1) CO6251249A2 (OSRAM)
CY (1) CY1116683T1 (OSRAM)
DK (1) DK2157973T3 (OSRAM)
ES (1) ES2545959T3 (OSRAM)
HR (1) HRP20150843T1 (OSRAM)
HU (1) HUE025902T2 (OSRAM)
IL (1) IL202053A (OSRAM)
MX (1) MX2009012583A (OSRAM)
MY (1) MY146407A (OSRAM)
NZ (1) NZ581099A (OSRAM)
PL (1) PL2157973T3 (OSRAM)
PT (1) PT2157973E (OSRAM)
RU (1) RU2469723C2 (OSRAM)
SI (1) SI2157973T1 (OSRAM)
TW (2) TWI423802B (OSRAM)
UA (1) UA96633C2 (OSRAM)
WO (1) WO2008143361A1 (OSRAM)
ZA (1) ZA200908202B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
HUE038653T2 (hu) 2011-03-01 2018-11-28 Pharnext Neurológiai rendellenességek baclofen és acamprosate alapú terápiája
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
BR112014031154A2 (pt) 2012-06-15 2017-08-08 Foundation For Biomedical Res And Innovation agente profilático e/ou terapêutico para deficiência cognitiva leve; e agente de melhoria do fluxo intersticial
WO2015100255A2 (en) * 2013-12-23 2015-07-02 Holaday John W Disposable container for air hydration
WO2017199755A1 (ja) * 2016-05-19 2017-11-23 国立研究開発法人国立循環器病研究センター 認知症の予防及び／又は治療のための薬剤
MX385719B (es) 2017-05-24 2025-03-18 H Lundbeck As Combinacion de un antagonista del receptor 5-ht6 y un inhibidor de acetilcolinesterasa para su uso en el tratamiento de la enfermedad de alzheimer en una subpoblacion de pacientes portadores de alelos apoe4
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
ATE292116T1 (de) * 1998-01-16 2005-04-15 Eisai Co Ltd Verfahren zur herstellung von donepezilderivaten
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
JP2004189706A (ja) * 2002-12-13 2004-07-08 Eisai Co Ltd 高度アルツハイマー型痴呆治療剤
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Also Published As

Publication number Publication date
TW201412315A (zh) 2014-04-01
HRP20150843T1 (hr) 2015-09-11
HK1140422A1 (en) 2010-10-15
CN101754758B (zh) 2012-10-24
AU2008253977A1 (en) 2008-11-27
DK2157973T3 (en) 2015-08-17
IL202053A0 (en) 2010-06-16
WO2008143361A1 (en) 2008-11-27
UA96633C2 (uk) 2011-11-25
ZA200908202B (en) 2010-07-28
KR20100020482A (ko) 2010-02-22
HUE025902T2 (en) 2016-05-30
TW200904428A (en) 2009-02-01
NZ581099A (en) 2012-03-30
MX2009012583A (es) 2010-03-08
CA2687289C (en) 2015-09-15
PT2157973E (pt) 2015-10-14
RU2009147456A (ru) 2011-06-27
KR101441725B1 (ko) 2014-09-18
EP2937085B1 (en) 2019-07-10
CA2687289A1 (en) 2008-11-27
SI2157973T1 (sl) 2015-10-30
TWI489983B (zh) 2015-07-01
AU2008253977B2 (en) 2013-08-22
CN101754758A (zh) 2010-06-23
US20100298375A1 (en) 2010-11-25
CO6251249A2 (es) 2011-02-21
IL202053A (en) 2016-04-21
RU2469723C2 (ru) 2012-12-20
EP2937085A1 (en) 2015-10-28
EP2157973A1 (en) 2010-03-03
TWI423802B (zh) 2014-01-21
JP2010527993A (ja) 2010-08-19
ES2545959T3 (es) 2015-09-17
PL2157973T3 (pl) 2015-12-31
BRPI0811919A2 (pt) 2014-11-18
MY146407A (en) 2012-08-15
EP2157973B1 (en) 2015-07-15
HK1215384A1 (en) 2016-08-26
JP5153870B2 (ja) 2013-02-27
CY1116683T1 (el) 2017-03-15

Similar Documents

Publication Publication Date Title
AR066664A1 (es) Un medicamento para tratar enfermedad de alzheimer
CR20120289A (es) Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
BR112021019484A2 (pt) Compostos de diazina-amida ativos em termos pesticidas
BR112014008686A2 (pt) derivados de oxazina e uso dos mesmos no tratamento de doença
CR20140537A (es) Compuesto heterocíclico nitrogenado
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
CU20120015A7 (es) Piridina y pirazina como derivados de moduladores de la proteína kinasa
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2011007712A (es) Los ácido sórbico y benzoico y sus derivados aumentan la actividad de un neurofarmacéutico.
UY32848A (es) Compuestos heterocíclicos de oxima
UY32502A (es) Agentes antihelmínticos y su utilización
UY30835A1 (es) 8-alquinilxantinas y derivados
CO6460766A2 (es) Compuestos de haloalquil heteroaril benzamida
ECSP14006132A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
BR112017009647A2 (pt) 2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimer
UY31526A1 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
AR090241A1 (es) INHIBIDORES DE LA b-SECRETASA
DOP2010000137A (es) Derivados de 1,2,3-triazol como inhibidores de estearoil-coenzima a desaturasa
MX2020005738A (es) Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida.
BR112015006524A2 (pt) derivados de quinazolinona como inibidores de parp
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
CO2020000240A2 (es) Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico
AR067446A1 (es) Un medicamento para tratar higado graso que comprende cilostazol
BR112015023013A2 (pt) inibidores de quinase cdk9

Legal Events

Date Code Title Description
FB Suspension of granting procedure